KASTx Life Sciences Fund I Closes First Funding Round
Syantra Receives CE Mark Approval for their Breast Cancer Test Built on the Syantra DX™ Liquid Biopsy Platform
GlycoNet and partners invest $1.7M in Canadian-led health research and bioinnovation
Canada needs to invest now to address antimicrobial resistance
